Schedule 13G ownership disclosure
Supernus Pharmaceuticals Inc
Common Stock · CUSIP: 868459108
Event date: 2025-03-31
- Filing-level shares
- 8,197,023.00
- Percent of class
- 14.7%
- BlackRock, Inc.
Shares: 8,197,023.00 · Class: 14.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-000381
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Apr 22, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership